Novoeight Email to HCPs: Are your patients affected by formulary changes?
Brand: Novoeight (antihemophilic factor), Intravenous Infusion
Parent Company: Novo Nordisk
Drug Type: Prescription
Drug Category: Hematology
Campaign: Post-Launch
Targeting: HCPs
Patient Website: https://www.novoeight.com/
HCP Website: https://www.novoeightpro.com/